PROTAC Bcl2 degrader-1 - HY-125876
Nur noch %1 verfügbar
Catalog #
HY-125876
Ab
568,00 €
PROTAC Bcl2 degrader-1 (Compound C5) is a PROTAC based on Cereblon ligand, which potently and selectively induces the degradation of Bcl-2 (IC50, 4.94 μM; DC50, 3.0 μM) and Mcl-1 (IC50, 11.81 μM) by introducing the E3 ligase cereblon (CRBN)-binding ligand pomalidomide to Mcl-1/Bcl-2 dual inhibitor Nap-1[1] (Blue: CRBN ligand, Black: linker;Pink: Mcl-1/Bcl-2 inhibitor, Nap-1).
| Datasheet URL | http://file.medchemexpress.com/batch_PDF/HY-125876/PROTAC-Bcl2-degrader-1-DataSheet-MedChemExpress.pdf |
|---|---|
| Shipping | Blue Ice |
| Application | Cancer-programmed cell death |
| CAS | 2378801-85-3 |
| Storage | -20°C (Powder, stored under nitrogen) |
| MWT | 941.84 |
| Solubility | DMSO : 25 mg/mL (ultrasonic) |
| Clinical Information | No Development Reported |
| Target | Bcl-2 Family;PROTACs |
| Application: | Cancer-programmed cell death |
|---|